Statistics: Int J Pharmaceutical Phytopharmacol Res
Geo Map
Region
#
AF - Africa
16
NA - North America
14
EU - Europe
11
AS - Asia, other
3
Unknown
61
Total
105
Country
#
US - United States of America
14
EG - Egypt
13
FI - Finland
4
KR - Korea
3
TR - Turkey
3
CI - Cote d'Ivoire
2
DE - Germany
2
RU - Russian Federation
2
SN - Senegal
1
Unknown
61
Total
105
City
#
Mountain View
7
Al Fayyum
6
Cairo
4
Seoul
3
Mersin
2
Washington
2
West Chester
2
Abidjan
1
Béoumi
1
Erzincan
1
other
76
Total
105
Most viewed items
#
ID: 2414 - Isolation, Characterization and Anticancer Activity of Seven Compounds from the Aerial Parts of Conyza triloba
55
Total
55
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
2 5 0 1
0 1
9
2020
2 0
4 0 0 3
3 3 0 3
0 0
18
2021
2 1
0 0 0 0
1 5 0 1
0 2
12
2022
0 1
1 1 1 0
1 0 0 9
0 2
16
2023
4 1
1 0 3 1
0 2 5 0
0 8
25
2024
2 0
0 4 2 3
0 0 0 0
0 0
11
Ever
105
Geo Map
Region | # |
---|---|
AF - Africa | 16 |
NA - North America | 14 |
EU - Europe | 11 |
AS - Asia, other | 3 |
Unknown | 61 |
Total | 105 |
Country | # |
---|---|
US - United States of America | 14 |
EG - Egypt | 13 |
FI - Finland | 4 |
KR - Korea | 3 |
TR - Turkey | 3 |
CI - Cote d'Ivoire | 2 |
DE - Germany | 2 |
RU - Russian Federation | 2 |
SN - Senegal | 1 |
Unknown | 61 |
Total | 105 |
City | # |
---|---|
Mountain View | 7 |
Al Fayyum | 6 |
Cairo | 4 |
Seoul | 3 |
Mersin | 2 |
Washington | 2 |
West Chester | 2 |
Abidjan | 1 |
Béoumi | 1 |
Erzincan | 1 |
other | 76 |
Total | 105 |
Most viewed items | # |
---|---|
ID: 2414 - Isolation, Characterization and Anticancer Activity of Seven Compounds from the Aerial Parts of Conyza triloba | 55 |
Total | 55 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 5 | 0 | 1 | 0 | 1 | 9 |
2020 | 2 | 0 | 4 | 0 | 0 | 3 | 3 | 3 | 0 | 3 | 0 | 0 | 18 |
2021 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 1 | 0 | 2 | 12 |
2022 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 9 | 0 | 2 | 16 |
2023 | 4 | 1 | 1 | 0 | 3 | 1 | 0 | 2 | 5 | 0 | 0 | 8 | 25 |
2024 | 2 | 0 | 0 | 4 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 11 |
Ever | 105 |